Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers.

Olsen JR, Apisarnthanarax S, Murphy JD, Tait D, Huguet F, Hallemeier CL, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037. Review. No abstract available.

PMID:
31422802
2.

Are methane emissions from mangrove stems a cryptic carbon loss pathway? Insights from a catastrophic forest mortality.

Jeffrey LC, Reithmaier G, Sippo JZ, Johnston SG, Tait DR, Harada Y, Maher DT.

New Phytol. 2019 Oct;224(1):146-154. doi: 10.1111/nph.15995. Epub 2019 Jul 20.

PMID:
31211874
3.

Exacerbation of the credit assignment problem in rats with lesions of the medial prefrontal cortex is revealed by Bayesian analysis of behavior in the pre-solution period of learning.

Wang J, Tait DS, Brown VJ, Bowman EM.

Behav Brain Res. 2019 Oct 17;372:112037. doi: 10.1016/j.bbr.2019.112037. Epub 2019 Jun 13.

PMID:
31202862
4.

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.

Sclafani F, Wilson SH, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, Wotherspoon A, Capdevila J, Glimelius B, Roselló S, Thomas J, Tait D, Brown G, Oates J, Chau I.

Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32507. [Epub ahead of print]

PMID:
31199501
5.

iAMES: An inexpensive, Automated Methane Ebullition Sensor.

Maher DT, Drexl M, Tait DR, Johnston SG, Jeffrey LC.

Environ Sci Technol. 2019 Jun 4;53(11):6420-6426. doi: 10.1021/acs.est.9b01881. Epub 2019 May 23.

PMID:
31117543
6.

Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers.

Hallemeier CL, Olsen JR, Murphy JD, Tait D, Apisarnthanarax S, Huguet F, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):1-9. doi: 10.1016/j.ijrobp.2018.12.052. No abstract available.

PMID:
30967220
7.

Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.

Norris EJ, Zhang Q, Jones WD, DeStephanis D, Sutker AP, Livasy CA, Ganapathi RN, Tait DL, Ganapathi MK.

J Pathol. 2019 Jul;248(3):352-362. doi: 10.1002/path.5264. Epub 2019 May 14.

8.

More rapid reversal learning following overtraining in the rat is evidence that behavioural and cognitive flexibility are dissociable.

Dhawan SS, Tait DS, Brown VJ.

Behav Brain Res. 2019 May 2;363:45-52. doi: 10.1016/j.bbr.2019.01.055. Epub 2019 Jan 30.

PMID:
30710612
9.

Author's Reply.

Brown J, Drury L, Crane EK, Anderson WE, Tait DL, Higgins RV, Naumann RW.

J Minim Invasive Gynecol. 2019 Mar - Apr;26(3):574. doi: 10.1016/j.jmig.2018.11.017. Epub 2018 Nov 30. No abstract available.

PMID:
30508654
10.

Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.

Naumann RW, Morris JC, Tait DL, Higgins RV, Crane EK, Drury LK, Amacker-North L, Templin M, Brown J.

Gynecol Oncol. 2018 Dec;151(3):477-480. doi: 10.1016/j.ygyno.2018.10.003. Epub 2018 Oct 8.

PMID:
30309722
11.

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Van Der Meeren O, Hatherill M, Nduba V, Wilkinson RJ, Muyoyeta M, Van Brakel E, Ayles HM, Henostroza G, Thienemann F, Scriba TJ, Diacon A, Blatner GL, Demoitié MA, Tameris M, Malahleha M, Innes JC, Hellström E, Martinson N, Singh T, Akite EJ, Khatoon Azam A, Bollaerts A, Ginsberg AM, Evans TG, Gillard P, Tait DR.

N Engl J Med. 2018 Oct 25;379(17):1621-1634. doi: 10.1056/NEJMoa1803484. Epub 2018 Sep 25.

12.

Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.

Athauda A, Watkins D, Mohammed K, Chau I, Starling N, Rao S, Tait D, Aitken K, Cunningham D.

Anticancer Res. 2018 Oct;38(10):5943-5949. doi: 10.21873/anticanres.12940.

PMID:
30275223
13.

When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.

Brown J, Drury L, Crane EK, Anderson WE, Tait DL, Higgins RV, Naumann RW.

J Minim Invasive Gynecol. 2019 Jul - Aug;26(5):902-909. doi: 10.1016/j.jmig.2018.09.765. Epub 2018 Sep 18.

PMID:
30240899
14.

Neoadjuvant rectal score: run with the hare and hunt with the hounds.

Sclafani F, Kalaitzaki E, Cunningham D, Tait D, Brown G, Chau I.

Ann Oncol. 2018 Nov 1;29(11):2261-2262. doi: 10.1093/annonc/mdy403. No abstract available.

PMID:
30204839
15.

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.

Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Andersen P, Scriba TJ, Hatherill M; H56-035 Trial Group.

Am J Respir Crit Care Med. 2019 Jan 15;199(2):220-231. doi: 10.1164/rccm.201802-0366OC.

PMID:
30092143
16.

Is organ preservation in rectal cancer ready for prime time?

Tekkis P, Tait D, Cunningham D, Brown G.

Lancet. 2018 Jun 23;391(10139):2480-2482. doi: 10.1016/S0140-6736(18)31324-2. No abstract available.

PMID:
29976455
17.

Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1.

Norris EJ, Jones WD, Surleac MD, Petrescu AJ, Destephanis D, Zhang Q, Hamadeh I, Kneisl JS, Livasy CA, Ganapathi RN, Tait DL, Ganapathi MK.

Gynecol Oncol Rep. 2018 Jan 17;23:41-44. doi: 10.1016/j.gore.2018.01.005. eCollection 2018 Feb.

18.

Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Bhoday J, Glimelius B, Tait D, Glynne-Jones R, Adams R, Brown G.

Colorectal Dis. 2018 May;20 Suppl 1:97-99. doi: 10.1111/codi.14088.

PMID:
29878687
19.

Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?

Dattani M, Marijnen C, Moran B, Tait D, Cunningham C, Rodriguez-Bigas M, Brown G.

Colorectal Dis. 2018 May;20 Suppl 1:92-96. doi: 10.1111/codi.14087.

PMID:
29878670
20.

A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling.

Brown J, Athens A, Tait DL, Crane EK, Higgins RV, Naumann RW, Gusic LH, Amacker-North L.

Int J Gynecol Cancer. 2018 Jun;28(5):996-1002. doi: 10.1097/IGC.0000000000001256.

PMID:
29664846
21.

Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.

Bernier L, Balyasnikova S, Tait D, Brown G.

Curr Colorectal Cancer Rep. 2018;14(2):37-55. doi: 10.1007/s11888-018-0398-5. Epub 2018 Mar 7. Review.

22.

Oral dosing of rodents using a palatable tablet.

Dhawan SS, Xia S, Tait DS, Bundgaard C, Bowman E, Brown VJ.

Psychopharmacology (Berl). 2018 May;235(5):1527-1532. doi: 10.1007/s00213-018-4863-2. Epub 2018 Mar 6.

23.

Assessment of intradimensional/extradimensional attentional set-shifting in rats.

Tait DS, Bowman EM, Neuwirth LS, Brown VJ.

Neurosci Biobehav Rev. 2018 Jun;89:72-84. doi: 10.1016/j.neubiorev.2018.02.013. Epub 2018 Feb 21. Review.

PMID:
29474818
24.

Impact of audiovisual biofeedback on interfraction respiratory motion reproducibility in liver cancer stereotactic body radiotherapy.

Pollock S, Tse R, Martin D, McLean L, Pham M, Tait D, Estoesta R, Whittington G, Turley J, Kearney C, Cho G, Hill R, Pickard S, Aston P, Makhija K, O'Brien R, Keall P.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):133-139. doi: 10.1111/1754-9485.12702.

PMID:
29405637
25.

HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.

Miller KR, Patel JN, Zhang Q, Norris EJ, Symanowski J, Michener C, Sehouli J, Braicu I, Destephanis DD, Sutker AP, Jones W, Livasy CA, Biscotti C, Ganapathi RN, Tait DL, Ganapathi MK.

Gynecol Oncol. 2018 Apr;149(1):155-162. doi: 10.1016/j.ygyno.2018.01.022.

PMID:
29402501
26.

Target volume motion during anal cancer image guided radiotherapy using cone-beam computed tomography.

Brooks CJ, Bernier L, Hansen VN, Tait DM.

Br J Radiol. 2018 May;91(1085):20170654. doi: 10.1259/bjr.20170654. Epub 2018 Mar 6.

27.

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

Sclafani F, Chau I, Cunningham D, Hahne JC, Vlachogiannis G, Eltahir Z, Lampis A, Braconi C, Kalaitzaki E, De Castro DG, Wotherspoon A, Capdevila J, Glimelius B, Tarazona N, Begum R, Lote H, Hulkki Wilson S, Mentrasti G, Brown G, Tait D, Oates J, Valeri N.

Sci Rep. 2018 Jan 23;8(1):1445. doi: 10.1038/s41598-018-19212-5.

28.

Dysregulation of AKT3 along with a small panel of mRNAs stratifies high-grade serous ovarian cancer from both normal epithelia and benign tumor tissues.

Yeganeh PN, Richardson C, Bahrani-Mostafavi Z, Tait DL, Mostafavi MT.

Genes Cancer. 2017 Nov;8(11-12):784-798. doi: 10.18632/genesandcancer.164.

29.

Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer.

Balyasnikova S, Read J, Wotherspoon A, Rasheed S, Tekkis P, Tait D, Cunningham D, Brown G.

BMJ Open Gastroenterol. 2017 Aug 14;4(1):e000151. doi: 10.1136/bmjgast-2017-000151. eCollection 2017.

30.

Greenhouse Gas Dynamics in a Salt-Wedge Estuary Revealed by High Resolution Cavity Ring-Down Spectroscopy Observations.

Tait DR, Maher DT, Wong W, Santos IR, Sadat-Noori M, Holloway C, Cook PLM.

Environ Sci Technol. 2017 Dec 5;51(23):13771-13778. doi: 10.1021/acs.est.7b04627. Epub 2017 Nov 22.

PMID:
29116768
31.

Challenging nurse student selection policy: Using a lifeworld approach to explore the link between care experience and student values.

Scammell J, Tait D, White S, Tait M.

Nurs Open. 2017 Jul 16;4(4):218-229. doi: 10.1002/nop2.88. eCollection 2017 Oct.

32.

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.

Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes LST, Balyasnikova S, Evans J, Peckitt C, Begum R, Tait D, Tabernero J, Glimelius B, Roselló S, Thomas J, Oates J, Chau I.

Br J Cancer. 2017 Nov 7;117(10):1478-1485. doi: 10.1038/bjc.2017.320. Epub 2017 Sep 21.

33.

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Battersby NJ, Dattani M, Rao S, Cunningham D, Tait D, Adams R, Moran BJ, Khakoo S, Tekkis P, Rasheed S, Mirnezami A, Quirke P, West NP, Nagtegaal I, Chong I, Sadanandam A, Valeri N, Thomas K, Frost M, Brown G.

Trials. 2017 Aug 29;18(1):394. doi: 10.1186/s13063-017-2085-2.

34.

Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.

Wedlake L, Shaw C, McNair H, Lalji A, Mohammed K, Klopper T, Allan L, Tait D, Hawkins M, Somaiah N, Lalondrelle S, Taylor A, VanAs N, Stewart A, Essapen S, Gage H, Whelan K, Andreyev HJN.

Am J Clin Nutr. 2017 Sep;106(3):849-857. doi: 10.3945/ajcn.116.150565. Epub 2017 Jul 5.

PMID:
28679552
35.

Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.

Sclafani F, Brown G, Cunningham D, Rao S, Tekkis P, Tait D, Morano F, Baratelli C, Kalaitzaki E, Rasheed S, Watkins D, Starling N, Wotherspoon A, Chau I.

Oncologist. 2017 Jun;22(6):728-736. doi: 10.1634/theoncologist.2016-0396. Epub 2017 May 5.

36.

Squamous Cell Carcinoma of the Anal Transitional Zone after Ileal Pouch Surgery for Ulcerative Colitis: Systematic Review and Treatment Perspectives.

Pellino G, Kontovounisios C, Tait D, Nicholls J, Tekkis PP.

Case Rep Oncol. 2017 Jan 27;10(1):112-122. doi: 10.1159/000455898. eCollection 2017 Jan-Apr.

37.

Clinical Testing of Tuberculosis Vaccine Candidates.

Hatherill M, Tait D, McShane H.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0015-2016. Review.

PMID:
28087924
38.

The selection process can improve the outcome in locally advanced and recurrent colorectal cancer: activity and results of a dedicated multidisciplinary colorectal cancer centre.

Kontovounisios C, Tan E, Pawa N, Brown G, Tait D, Cunningham D, Rasheed S, Tekkis P.

Colorectal Dis. 2017 Apr;19(4):331-338. doi: 10.1111/codi.13517.

39.

Effects of lesions of the subthalamic nucleus/zona incerta area and dorsomedial striatum on attentional set-shifting in the rat.

Tait DS, Phillips JM, Blackwell AD, Brown VJ.

Neuroscience. 2017 Mar 14;345:287-296. doi: 10.1016/j.neuroscience.2016.08.008. Epub 2016 Aug 12.

40.

The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery.

Balyasnikova S, Read J, Tait D, Wotherspoon A, Swift I, Cunningham D, Tekkis P, Brown G.

Colorectal Dis. 2017 Feb;19(2):139-147. doi: 10.1111/codi.13477.

41.

Epidemiologic studies and novel clinical research approaches that impact TB vaccine development.

Evans TG, Churchyard GJ, Penn-Nicholson A, Chen C, Gao X, Tait DR, Hatherill M.

Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S21-5. doi: 10.1016/j.tube.2016.05.008. Epub 2016 Jun 11.

42.

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

Sclafani F, Chau I, Cunningham D, Lampis A, Hahne JC, Ghidini M, Lote H, Zito D, Tabernero J, Glimelius B, Cervantes A, Begum R, De Castro DG, Wilson SH, Peckitt C, Eltahir Z, Wotherspoon A, Tait D, Brown G, Oates J, Braconi C, Valeri N.

Carcinogenesis. 2016 Sep;37(9):852-7. doi: 10.1093/carcin/bgw073. Epub 2016 Jul 5.

43.

Fresh meteoric versus recirculated saline groundwater nutrient inputs into a subtropical estuary.

Sadat-Noori M, Santos IR, Tait DR, Maher DT.

Sci Total Environ. 2016 Oct 1;566-567:1440-1453. doi: 10.1016/j.scitotenv.2016.06.008. Epub 2016 Jun 17.

PMID:
27320738
44.

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.

Sclafani F, Brown G, Cunningham D, Wotherspoon A, Tait D, Peckitt C, Evans J, Yu S, Sena Teixeira Mendes L, Tabernero J, Glimelius B, Cervantes A, Thomas J, Begum R, Oates J, Chau I.

Ann Oncol. 2016 Aug;27(8):1557-65. doi: 10.1093/annonc/mdw215. Epub 2016 May 23.

PMID:
27217542
45.

Pristine mangrove creek waters are a sink of nitrous oxide.

Maher DT, Sippo JZ, Tait DR, Holloway C, Santos IR.

Sci Rep. 2016 May 12;6:25701. doi: 10.1038/srep25701.

46.

Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity Assessment.

De Francesco I, Thomas K, Wedlake L, Tait D.

Clin Oncol (R Coll Radiol). 2016 Sep;28(9):604-10. doi: 10.1016/j.clon.2016.04.039. Epub 2016 May 5.

PMID:
27156162
47.

Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer.

Miller KR, Patel JN, Ganapathi MK, Tait DL, Ganapathi RN.

Gynecol Oncol. 2016 Jun;141(3):608-615. doi: 10.1016/j.ygyno.2016.03.004. Epub 2016 Mar 21. Review.

PMID:
26957480
48.

Attentional Set-Shifting Across Species.

Brown VJ, Tait DS.

Curr Top Behav Neurosci. 2016;28:363-95. doi: 10.1007/7854_2015_5002. Review.

PMID:
26873018
49.

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.

Khan K, Cunningham D, Peckitt C, Barton S, Tait D, Hawkins M, Watkins D, Starling N, Rao S, Begum R, Thomas J, Oates J, Guzzardo V, Fassan M, Braconi C, Chau I.

Oncotarget. 2016 Mar 15;7(11):12672-81. doi: 10.18632/oncotarget.7208.

50.

Carbon cycling and exports over diel and flood-recovery timescales in a subtropical rainforest headwater stream.

Looman A, Santos IR, Tait DR, Webb JR, Sullivan CA, Maher DT.

Sci Total Environ. 2016 Apr 15;550:645-657. doi: 10.1016/j.scitotenv.2016.01.082. Epub 2016 Feb 2.

PMID:
26849329

Supplemental Content

Support Center